Meniere's disease: new guidelines, subtypes, imaging, and more

Purpose of review This article reviews recent developments in Meniere's disease including etiologic, diagnostic, and therapeutic investigations that have changed the landscape for medical providers. These updates shed light onto the complex nature of Meniere's disease and generate additional means to provide optimal care to patients. Recent findings Given the multifactorial cause of Meniere's disease, five subtypes of Meniere's disease have recently been proposed. A knowledge of these subtypes will aid in the development of an appropriate treatment algorithm. Although newer treatments have not been developed, stepwise treatment algorithms have been proposed and can improve patient care. New MRI modalities and serum testing hold promise as clinical clues and biomarkers. As these updated diagnostic criteria are used, Meniere's disease can be identified and treated more precisely. This will in turn allow for future randomized controlled studies to improve the quality of treatment options available. Future imaging, vestibular testing, and the potential for serum biomarkers may illuminate additional diagnostic criteria, only furthering the improvement in clinical care.

Automated summary

Recent developments in Meniere's disease have led to the proposal of five subtypes, aiding in the development of appropriate treatment algorithms. Although newer treatments have not been developed, stepwise treatment algorithms have been suggested to improve patient care. New MRI modalities and serum testing hold promise as potential clinical clues and biomarkers for improved diagnosis and treatment.